In the original version of this article (1), the values stated for fub,abemaciclib, fub,M2, and fub,M20 in the legend for Fig. 3 were incorrect. These values have been corrected in the latest online HTML and PDF versions of this article. The authors regret these errors.

1.
Tolaney
 
SM
,
Sahebjam
 
S
,
Le Ruhn
 
E
,
Bachelot
 
T
,
Kabos
 
P
,
Awada
 
A
, et al 
A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor-positive breast cancer
.
Clin Cancer Res
 
2020
;
26
:
5310
–
9
.
Google Scholar
Crossref
Search ADS
 
View Original Article
©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.